# American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

> **NCT02674100** · — · RECRUITING · sponsor: **University of Louisville** · enrollment: 500 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** Registry

## Key facts

- **NCT ID:** NCT02674100
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674100, "American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02674100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*